{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:41:22Z","timestamp":1792597282624,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"39","license":[{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,9,26]]},"DOI":"10.1038\/onc.2012.468","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T11:14:07Z","timestamp":1351509247000},"page":"4712-4720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells"],"prefix":"10.1038","volume":"32","author":[{"given":"N","family":"Kliese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Gobrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pachow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Andrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wilisch-Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Kirches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Riek-Burchardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Angenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Reifenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Riemenschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Meese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Panayotova-Dimitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"key":"BFonc2012468_CR1","unstructured":"CBTRUS. Central brain tumor registry of the United States 2012."},{"key":"BFonc2012468_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin C, Perry A . Pathological classification and molecular genetics of meningiomas. J Neurooncol 2010; 99: 379\u2013391.","journal-title":"J Neurooncol"},{"key":"BFonc2012468_CR3","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC . \"Malignancy\" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85: 2046\u20132056.","journal-title":"Cancer"},{"key":"BFonc2012468_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0002-9440(10)64222-8","volume":"161","author":"MA Watson","year":"2002","unstructured":"Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 2002; 161: 665\u2013672.","journal-title":"Am J Pathol"},{"key":"BFonc2012468_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3182018f1c","volume":"70","author":"JE Stuart","year":"2011","unstructured":"Stuart JE, Lusis EA, Scheck AC, Coons SW, Lal A, Perry A et al. Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays. J Neuropathol Exp Neurol 2011; 70: 1\u201312.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFonc2012468_CR6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/neuonc\/noq004","volume":"12","author":"D Haase","year":"2010","unstructured":"Haase D, Schmidl S, Ewald C, Kalff R, Huebner C, Firsching R et al. Fatty acid synthase as a novel target for meningioma therapy. Neuro Oncol 2010; 12: 844\u2013854.","journal-title":"Neuro Oncol"},{"key":"BFonc2012468_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1750-3639.2009.00267.x","volume":"20","author":"C Mawrin","year":"2009","unstructured":"Mawrin C, Wolke C, Haase D, Kr\u00fcger S, Firsching R, Keilhoff G et al. Reduced Activity of CD13\/aminopeptidase N (APN) in aggressive meningiomas is associated with increased levels of SPARC. Brain Pathol 2009; 20: 200\u2013210.","journal-title":"Brain Pathol"},{"key":"BFonc2012468_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857\u2013866.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012468_CR9","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","volume":"64","author":"J Takamizawa","year":"2004","unstructured":"Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753\u20133756.","journal-title":"Cancer Res"},{"key":"BFonc2012468_CR10","doi-asserted-by":"publisher","first-page":"e18409","DOI":"10.1371\/journal.pone.0018409","volume":"6","author":"S Liang","year":"2011","unstructured":"Liang S, He L, Zhao X, Miao Y, Gu Y, Guo C et al. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 2011; 6: e18409.","journal-title":"PLoS One"},{"key":"BFonc2012468_CR11","doi-asserted-by":"publisher","first-page":"32582","DOI":"10.1074\/jbc.M702806200","volume":"282","author":"B Shi","year":"2007","unstructured":"Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R et al. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007; 282: 32582\u201332590.","journal-title":"J Biol Chem"},{"key":"BFonc2012468_CR12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.4161\/cc.8.14.9026","volume":"8","author":"G La Rocca","year":"2009","unstructured":"La Rocca G, Shi B, Badin M, De Angelis T, Sepp-Lorenzino L, Baserga R et al. Growth inhibition by microRNAs that target the insulin receptor substrate-1. Cell Cycle 2009; 8: 2255\u20132259.","journal-title":"Cell Cycle"},{"key":"BFonc2012468_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/onc.2012.61","volume":"32","author":"P Gao","year":"2012","unstructured":"Gao P, Xing A-Y, Zhou G-Y, Zhang T-G, Zhang J-P, Gao C et al. The molecular mechanism of microRNA-145 to suppress invasion\u2013metastasis cascade in gastric cancer. Oncogene 2012; 32: 491\u2013501.","journal-title":"Oncogene"},{"key":"BFonc2012468_CR14","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1038\/onc.2010.386","volume":"29","author":"M Gotte","year":"2010","unstructured":"Gotte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M et al. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 2010; 29: 6569\u20136580.","journal-title":"Oncogene"},{"key":"BFonc2012468_CR15","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1128\/MCB.00332-09","volume":"29","author":"O Saydam","year":"2009","unstructured":"Saydam O, Shen Y, Wurdinger T, Senol O, Boke E, James MF et al. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway. Mol Cell Biol 2009; 29: 5923\u20135940.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012468_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.bjc.6605742","volume":"103","author":"MS Zaman","year":"2010","unstructured":"Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, Saini S et al. The functional significance of microRNA-145 in prostate cancer. Br J Cancer 2010; 103: 256\u2013264.","journal-title":"Br J Cancer"},{"key":"BFonc2012468_CR17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/carcin\/bgr036","volume":"32","author":"SO Suh","year":"2011","unstructured":"Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V et al. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 2011; 32: 772\u2013778.","journal-title":"Carcinogenesis"},{"key":"BFonc2012468_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2407-12-143","volume":"12","author":"S Koo","year":"2012","unstructured":"Koo S, Martin GS, Schulz KJ, Ronck M, Toussaint LG . Serial selection for invasiveness increases expression of miR-143\/miR-145 in glioblastoma cell lines. BMC Cancer 2012; 12: 143.","journal-title":"BMC Cancer"},{"key":"BFonc2012468_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/00006123-199304000-00023","volume":"32","author":"PM Black","year":"1993","unstructured":"Black PM . Meningiomas. Neurosurgery 1993; 32: 643\u2013657.","journal-title":"Neurosurgery"},{"key":"BFonc2012468_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00006123-200207000-00026","volume":"51","author":"T Kilic","year":"2002","unstructured":"Kilic T, Bayri Y, Ozduman K, Acar M, Diren S, Kurtkaya O et al. Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery 2002; 51: 183\u2013192.","journal-title":"Neurosurgery"},{"key":"BFonc2012468_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3171\/jns.2001.95.5.0839","volume":"95","author":"AC Nordqvist","year":"2001","unstructured":"Nordqvist AC, Smurawa H, Mathiesen T . Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. J Neurosurg 2001; 95: 839\u2013844.","journal-title":"J Neurosurg"},{"key":"BFonc2012468_CR22","first-page":"547","volume":"60","author":"A De Paepe","year":"1997","unstructured":"De Paepe A, Nuytinck L, Hausser I, Anton-Lamprecht I, Naeyaert JM . Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet 1997; 60: 547\u2013554.","journal-title":"Am J Hum Genet"},{"key":"BFonc2012468_CR23","doi-asserted-by":"publisher","first-page":"E395","DOI":"10.1002\/humu.20887","volume":"30","author":"S Symoens","year":"2009","unstructured":"Symoens S, Malfait F, Renard M, Andr\u00e9 J, Hausser I, Loeys B et al. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome. Hum Mutat 2009; 30: E395\u2013E403.","journal-title":"Hum Mutat"},{"key":"BFonc2012468_CR24","doi-asserted-by":"publisher","first-page":"12888","DOI":"10.1074\/jbc.M511528200","volume":"281","author":"RJ Wenstrup","year":"2006","unstructured":"Wenstrup RJ, Florer JB, Davidson JM, Phillips CL, Pfeiffer BJ, Menezes DW et al. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem 2006; 281: 12888\u201312895.","journal-title":"J Biol Chem"},{"key":"BFonc2012468_CR25","first-page":"267","volume":"5","author":"H Nitta","year":"1990","unstructured":"Nitta H, Yamashima T, Yamashita J, Kubota T . An ultrastructural and immunohistochemical study of extracellular matrix in meningiomas. Histol Histopathol 1990; 5: 267\u2013274.","journal-title":"Histol Histopathol"},{"key":"BFonc2012468_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2990.2006.00761.x","volume":"32","author":"J Schittenhelm","year":"2006","unstructured":"Schittenhelm J, Mittelbronn M, Roser F, Tatagiba M, Mawrin C, Bornemann A et al. Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas. Neuropathol Appl Neurobiol 2006; 32: 525\u2013531.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFonc2012468_CR27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/labinvest.3700307","volume":"85","author":"S Puttmann","year":"2005","unstructured":"Puttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest 2005; 85: 1163\u20131171.","journal-title":"Lab Invest"},{"key":"BFonc2012468_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","volume":"27","author":"WH Lee","year":"1990","unstructured":"Lee WH . Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 1990; 27: 389\u2013395 discussion 396.","journal-title":"Neurosurgery"},{"key":"BFonc2012468_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.surneu.2007.06.031","volume":"70","author":"BT Ragel","year":"2008","unstructured":"Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL et al. A comparison of the cell lines used in meningioma research. Surg Neurol 2008; 70: 295\u2013307.","journal-title":"Surg Neurol"},{"key":"BFonc2012468_CR30","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/1097-0142(19891201)64:11<2243::AID-CNCR2820641110>3.0.CO;2-S","volume":"64","author":"K Tanaka","year":"1989","unstructured":"Tanaka K, Sato C, Maeda Y, Koike M, Matsutani M, Yamada K et al. Establishment of a human malignant meningioma cell line with amplified c-myc oncogene. Cancer 1989; 64: 2243\u20132249.","journal-title":"Cancer"},{"key":"BFonc2012468_CR31","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/labinvest.2011.130","volume":"91","author":"E Kirches","year":"1766","unstructured":"Kirches E, Andrae N, Hoefer A, Kehler B, Zarse K, Leverkus M et al. Dual role of the mitochondrial protein frataxin in astrocytic tumors. Lab Invest 1766; 91: 1766\u20131776.","journal-title":"Lab Invest"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012468","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T14:18:20Z","timestamp":1647872300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":31,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2013,9,26]]}},"alternative-id":["BFonc2012468"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.468","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,29]]},"assertion":[{"value":"8 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}